Medicare has historically excluded weight-loss drugs, though the Medicare GLP-1 Bridge demonstration is set to begin July 2026 with a $50/month copay for eligible Part D beneficiaries on Wegovy or Zepbound
Clinical Trials Journal 1986;23(6):338-344
Genetics of Insulin Resistance and the Metabolic Syndrome
188,189,190 For pregnant women, the COVID-19 vaccine may cause adverse events, such as abortion, premature birth, or fetal malformation
Our GLP-1 Daily Support supplement is designed to complement your medication by providing essential nutrients that support digestion and energy levels
While Ozempic can lead to weight loss as a side effect, it is not specifically approved for weight management